125 related articles for article (PubMed ID: 8781436)
1. Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation.
Zhao Q; Song X; Waldschmidt T; Fisher E; Krieg AM
Blood; 1996 Sep; 88(5):1788-95. PubMed ID: 8781436
[TBL] [Abstract][Full Text] [Related]
2. [Oligonucleotide uptake in hematological tumor cells is related to cellular species and proliferation].
Zhu YG; Zhuo GS; Chen ZZ; Chen XC
Yao Xue Xue Bao; 2003 Jun; 38(6):401-4. PubMed ID: 14513795
[TBL] [Abstract][Full Text] [Related]
3. Binding of antisense phosphorothioate oligonucleotides to murine lymphocytes is lineage specific and inducible.
Iversen PL; Crouse D; Zon G; Perry G
Antisense Res Dev; 1992; 2(3):223-33. PubMed ID: 1490073
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 rev antisense phosphorothioate oligonucleotide binding to human mononuclear cells is cell type specific and inducible.
Pirruccello SJ; Perry GA; Bock PJ; Lang MS; Noel SM; Zon G; Iversen PL
Antisense Res Dev; 1994; 4(4):285-9. PubMed ID: 7734943
[TBL] [Abstract][Full Text] [Related]
5. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
6. Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging.
Calabretta B; Sims RB; Valtieri M; Caracciolo D; Szczylik C; Venturelli D; Ratajczak M; Beran M; Gewirtz AM
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2351-5. PubMed ID: 2006173
[TBL] [Abstract][Full Text] [Related]
7. Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset.
Kronenwett R; Steidl U; Kirsch M; Sczakiel G; Haas R
Blood; 1998 Feb; 91(3):852-62. PubMed ID: 9446645
[TBL] [Abstract][Full Text] [Related]
8. Different effects of an oligonucleotide uptake stimulating protein on leukemic cells in their primitive and differentiated state.
Tóth G; Schlammadinger J; Sipka S; Kiss A; Szegedi G; Rák K; Szabó G
FEBS Lett; 1998 Jul; 430(3):241-5. PubMed ID: 9688547
[TBL] [Abstract][Full Text] [Related]
9. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
10. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
11. Potentially therapeutically relevant differences of antisense oligonucleotide uptake in CD34+ hematopoietic stem cells, leukemic blasts and cancer cells from patients.
Seitz G; Kohler G; Nehmzow M; Lorenz G; Denzlinger C; Müller C; Bader P; Brischwein K; Beck JF
Anticancer Res; 2002; 22(3):1717-9. PubMed ID: 12168859
[TBL] [Abstract][Full Text] [Related]
12. Liposomal delivery of oligodeoxynucleotides.
Tari A; Khodadadian M; Ellerson D; Deisseroth A; Lopez-Berestein G
Leuk Lymphoma; 1996 Mar; 21(1-2):93-7. PubMed ID: 8907275
[TBL] [Abstract][Full Text] [Related]
13. CREB antisense oligonucleotides induce non-apoptotic cell death in proliferating leukemia cells, but not normal hematopoietic cells, by a bizarre non-antisense mechanism.
Saeki K; Yuo A; Koizumi M; Fujiwara K; Kaneko M; Takaku F; Yazaki Y
Leukemia; 2001 Feb; 15(2):238-45. PubMed ID: 11236939
[TBL] [Abstract][Full Text] [Related]
14. Antisense c-myc oligonucleotide cellular uptake and activity.
Wu-Pong S; Weiss TL; Hunt CA
Antisense Res Dev; 1994; 4(3):155-63. PubMed ID: 7849486
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific oligonucleotide uptake in murine bone marrow B-cell precursors.
Zhao Q; Waldschmidt T; Fisher E; Herrera CJ; Krieg AM
Blood; 1994 Dec; 84(11):3660-6. PubMed ID: 7949121
[TBL] [Abstract][Full Text] [Related]
16. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
[TBL] [Abstract][Full Text] [Related]
17. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
18. c-kit expression by CD34+ bone marrow progenitors and inhibition of response to recombinant human interleukin-3 following exposure to c-kit antisense oligonucleotides.
Catlett JP; Leftwich JA; Westin EH; Grant S; Huff TF
Blood; 1991 Dec; 78(12):3186-91. PubMed ID: 1720696
[TBL] [Abstract][Full Text] [Related]
19. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia.
Inoue K; Ogawa H; Sonoda Y; Kimura T; Sakabe H; Oka Y; Miyake S; Tamaki H; Oji Y; Yamagami T; Tatekawa T; Soma T; Kishimoto T; Sugiyama H
Blood; 1997 Feb; 89(4):1405-12. PubMed ID: 9028964
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of a hematopoietic proteoglycan core protein gene during human hematopoiesis.
Stellrecht CM; Mars WM; Miwa H; Beran M; Saunders GF
Differentiation; 1991 Nov; 48(2):127-35. PubMed ID: 1723052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
